X

Sign up for Equitymaster's free daily newsletter, The 5 Minute WrapUp and get access to our latest Multibagger guide (2018 Edition) on picking money-making stocks.

This is an entirely free service. No payments are to be made.


Download Now Subscribe to our free daily e-letter, The 5 Minute WrapUp and get this complimentary report.
We hate spam as much as you do. Check out our Privacy Policy and Terms Of Use.
Compare IPCA Labs with Lupin Ltd - Equitymaster
  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

IPCA LABS vs LUPIN LTD - Comparison Results

IPCA LABS    Change

Ipca Laboratories is an integrated pharmaceutical company with presence in intermediates, APIs and formulations. The company has a strong focus on exports, catering to the US, Europe and the semi-regulated markets of the CIS, Africa and Asia. The com... More

LUPIN LTD 
   Change

Lupin is a leading pharmaceutical company with a strong presence in anti-infective, cardiovascular and asthma. Apart from having a strong domestic presence, the company markets its products in the regulated markets of the US and Europe and semi-regul... More

DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    IPCA LABS LUPIN LTD IPCA LABS/
LUPIN LTD
 
P/E (TTM) x 42.1 20.1 209.4% View Chart
P/BV x 3.2 2.7 118.5% View Chart
Dividend Yield % 0.2 0.9 17.3%  

Financials

 IPCA LABS   LUPIN LTD
EQUITY SHARE DATA
    IPCA LABS
Mar-17
LUPIN LTD
Mar-17
IPCA LABS/
LUPIN LTD
5-Yr Chart
Click to enlarge
High Rs6431,750 36.7%   
Low Rs5031,384 36.3%   
Sales per share (Unadj.) Rs254.4387.4 65.7%  
Earnings per share (Unadj.) Rs16.156.6 28.4%  
Cash flow per share (Unadj.) Rs29.876.8 38.8%  
Dividends per share (Unadj.) Rs1.007.50 13.3%  
Dividend yield (eoy) %0.20.5 36.5%  
Book value per share (Unadj.) Rs194.6298.9 65.1%  
Shares outstanding (eoy) m126.20451.58 27.9%   
Bonus/Rights/Conversions -ESOPS-  
Price / Sales ratio x2.34.0 55.7%   
Avg P/E ratio x35.727.7 128.9%  
P/CF ratio (eoy) x19.220.4 94.4%  
Price / Book Value ratio x2.95.2 56.2%  
Dividend payout %6.213.2 47.0%   
Avg Mkt Cap Rs m72,300707,513 10.2%   
No. of employees `00013.316.8 79.2%   
Total wages/salary Rs m6,96028,495 24.4%   
Avg. sales/employee Rs Th2,413.510,418.3 23.2%   
Avg. wages/employee Rs Th523.21,697.0 30.8%   
Avg. net profit/employee Rs Th152.41,523.0 10.0%   
INCOME DATA
Net Sales Rs m32,106174,943 18.4%  
Other income Rs m2261,065 21.2%   
Total revenues Rs m32,332176,008 18.4%   
Gross profit Rs m4,44844,931 9.9%  
Depreciation Rs m1,7309,122 19.0%   
Interest Rs m2411,525 15.8%   
Profit before tax Rs m2,70335,349 7.6%   
Minority Interest Rs m0-72 0.0%   
Prior Period Items Rs m083 0.0%   
Extraordinary Inc (Exp) Rs m00-   
Tax Rs m6759,785 6.9%   
Profit after tax Rs m2,02825,575 7.9%  
Gross profit margin %13.925.7 53.9%  
Effective tax rate %25.027.7 90.2%   
Net profit margin %6.314.6 43.2%  
BALANCE SHEET DATA
Current assets Rs m17,340119,542 14.5%   
Current liabilities Rs m9,55961,206 15.6%   
Net working cap to sales %24.233.3 72.7%  
Current ratio x1.82.0 92.9%  
Inventory Days Days10076 132.0%  
Debtors Days Days5790 63.3%  
Net fixed assets Rs m20,779131,660 15.8%   
Share capital Rs m252903 27.9%   
"Free" reserves Rs m24,499134,073 18.3%   
Net worth Rs m24,553134,976 18.2%   
Long term debt Rs m3,51756,478 6.2%   
Total assets Rs m39,595266,073 14.9%  
Interest coverage x12.224.2 50.6%   
Debt to equity ratio x0.10.4 34.2%  
Sales to assets ratio x0.80.7 123.3%   
Return on assets %5.710.2 56.3%  
Return on equity %8.318.9 43.6%  
Return on capital %10.519.3 54.4%  
Exports to sales %48.60-   
Imports to sales %14.20-   
Exports (fob) Rs m15,617NA-   
Imports (cif) Rs m4,571NA-   
Fx inflow Rs m15,61781,885 19.1%   
Fx outflow Rs m5,82821,506 27.1%   
Net fx Rs m9,79060,378 16.2%   
CASH FLOW
From Operations Rs m2,76441,148 6.7%  
From Investments Rs m-1,432-25,287 5.7%  
From Financial Activity Rs m-1,5914,332 -36.7%  
Net Cashflow Rs m-25920,193 -1.3%  

Share Holding

Indian Promoters % 45.9 46.6 98.5%  
Foreign collaborators % 0.0 0.2 -  
Indian inst/Mut Fund % 11.4 11.3 100.9%  
FIIs % 25.3 31.9 79.3%  
ADR/GDR % 0.0 0.0 -  
Free float % 17.4 10.1 172.3%  
Shareholders   36,892 98,259 37.5%  
Pledged promoter(s) holding % 2.1 0.0 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare IPCA LABS With:   ELDER PHARMA  FDC LTD.  SUN PHARMA  STRIDES SHASUN LTD  TTK HEALTHCARE  

Compare IPCA LABS With:   MYLAN (US)  ACTAVIS (US)  ADCOCK INGRAM (S. Africa)  TEVA PHARMA (Israel)  



Today's Market

Sensex Finishes Marginally Lower; Capital Goods & Realty Stocks Fall(Closing)

Indian share markets witnessed selling pressure in the final hour of trade to finish just below the dotted line. At the closing bell, the BSE Sensex closed lower by 71 points.

Related Views on News

Lupin: US market Declines Due to Higher Base Effect of FY17 (Quarterly Results Update - Detailed)

Feb 9, 2018

Price erosion in generic US drugs continues but seems to be bottoming out.

Lupin: US Markets Drags down Revenues and Net Profits (Quarterly Results Update - Detailed)

Nov 2, 2017

Domestic markets registers robust growth in the quarter

Lupin: Bigger Challenges or Bigger Margin of Safety? (Quarterly Results Update - Detailed)

Aug 14, 2017

GST impact coupled with price erosion in US leads to lower profits for the quarter.

Lupin: Decline in US Business Impacts Overall Growth (Quarterly Results Update - Detailed)

May 29, 2017

Currency fluctuation and one time provision impacts operating margins.

Aster DM Healthcare (IPO)

Feb 10, 2018

Should you subscribe to the IPO of Aster DM Healthcare Ltd?

More Views on News

Most Popular

Follow India's Super Investors to Make Big Money in the Market Crash(The 5 Minute Wrapup)

Feb 8, 2018

Has the sell-off in the markets left India's super investors unduly worried?

The Era of Easy Money is Coming to an End. What Happens Now?(Vivek Kaul's Diary)

Feb 9, 2018

The easy money policy of the Federal Reserve of the United States, which drove up stock markets all over the world, is ending, with the Federal Reserve looking to shrink its balance sheet.

The Markets Want Your Money. Don't Give It to Them.(Smart Contrarian)

Feb 9, 2018

MFs are having a gala time taking money from over-eager investors and funneling it into equities. Smart investors, though, know better than to do that.

The Big Gamble(The Honest Truth)

Feb 15, 2018

Once you accept the fact that elections are round the corner and that this budget is geared to reach a 40% target, everything makes sense.

Rising Dominance of Mutual Funds(Chart Of The Day)

Feb 8, 2018

Domestic money flow into Indian equities surpassed foreign fund flows in the recent years. But will it continue in volatile market?

More

Small Investments
BIG Returns

Zero To Millions Guide 2018
Get our special report, Zero To Millions
(2018 Edition) Now!
We will never sell or rent your email id.
Please read our Terms

IPCA LABS SHARE PRICE


Feb 20, 2018 (Close)

TRACK IPCA LABS

  • Track your investment in IPCA LABS with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

COMPARE IPCA LABS WITH

MARKET STATS